Delivery Order W81XWH16D0009-W81XWH19F0423
Award Date 7/22/19
Potential Completion Date 6/21/21
Potential Value $806K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Cost Plus Fixed Fee
Place of Performance
Seattle, WA 98109, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Health Agency awarded a $25.7 million cost-plus-fixed-fee delivery order to Inbios International Inc., a minority-owned biotechnology company headquartered in Seattle, Washington. The contract, issued on June 15, 2020, supports COVID-19 diagnostic development efforts through FDA Emergency Use Authorization antigen detection optimization and fast-track serology assay advancement. The work will be performed in Seattle and is scheduled for completion by May 31, 2025. This delivery order...
- This federal contract award, valued at $5,508,014.60, was issued by the Medical Command (MEDCOM) to Inbios International Inc., a minority-owned, for-profit biotechnology company based in Seattle, Washington. The contract is for Information and Communications Technology (ICT) Development on a Cost-Plus-Fixed-Fee (CPFF) basis, with a completion date of July 20, 2019. Inbios, a Subchapter S Corporation, is a manufacturer of immunodiagnostic devices for infectious diseases. This contract award...
- This is a federal contract award to Inbios International Inc., a minority-owned, for-profit biotechnology company based in Seattle, Washington. The contract, awarded by the Medical Command (MEDCOM) agency of the U.S. Department of Defense, is for ICT (Information and Communications Technology) development on a Cost-Plus-Fixed-Fee (CPFF) basis. The contract has a ceiling value of $1,724,742.02 and an ultimate completion date of September 18, 2019. The contract is not set-aside and was awarded...
- This is a federal contract award to Inbios International Inc., a minority-owned, for-profit biotechnology company based in Seattle, Washington. The contract, awarded by the U.S. Army Medical Command (MEDCOM), is for a Small Business Innovation Research (SBIR) Phase II project, valued at $891,867.91. The contract is a Definitive Contract with a Cost Plus Fixed Fee pricing type, and the ultimate completion date is January 14, 2020. Inbios International Inc. is a specialized manufacturer of...
- This federal contract award to Inbios International Inc., a minority-owned business based in Seattle, Washington, was issued by the Office of the Assistant Secretary for Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS). The $749,998 firm fixed-price contract supports research and development (R&D) of an antibody diagnostic for COVID-19. The contract was issued under a Broad Agency Announcement (BAA) solicitation from ASPR's Division of...
- This federal contract award, HHSD2002017M93163P, was made by the Centers for Disease Control and Prevention (CDC) to Inbios International Inc., a minority-owned, for-profit biotechnology company based in Seattle, Washington. The $198,492.00 firm fixed-price purchase order is for INBIOS EQUIPMENT, with an ultimate completion date of July 14, 2017. The contract was awarded on March 9, 2017, and was not set aside for any specific business type. Inbios International is a key partner to multiple...
- This federal contract award, valued at $4,708.00, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Inbios International Inc., a minority-owned biotechnology company based in Seattle, Washington. The contract is for the procurement of "TEST KIT,VISCERAL L" and has a completion date of June 24, 2024. Inbios International Inc. is a veteran-owned, for-profit organization that specializes in the design, development, and manufacture of immunodiagnostic...
- This is a federal contract award to Inbios International Inc., a minority-owned, for-profit biotechnology company based in Seattle, Washington. The contract, valued at $2,343,473.90, was awarded by the Office of Naval Research (ONR) and is for "DIAGNOSTICS TECHNOLOGIES AND TIERED EVALUATION" work. The contract is a Definitive Contract with a Cost Plus Fixed Fee pricing type and has an ultimate completion date of January 2, 2019. The contract does not have a set-aside designation....
- This federal contract award, W81XWH15P0522, was made by the U.S. Medical Command (MEDCOM) to Inbios International Inc., a minority-owned, for-profit biotechnology company based in Seattle, Washington. The $95,000.00 firm fixed-price purchase order contract was set aside for small businesses and has an ultimate completion date of October 15, 2015. The contract is for NORO-RD products, which likely refers to diagnostic devices or related medical technology. Inbios International is a critical...
- The Department of State Bureau of East Asian and Pacific Affairs awarded a firm fixed-price purchase order to Inbios International Inc., a minority-owned, for-profit biotechnology company based in Seattle, Washington, for $143,218.00. The contract is for the supply of CDC 7553.0/ELISA detection kits, which are immunodiagnostic devices used for infectious disease testing. Inbios has a history of federal contract awards and grants related to the development and manufacture of diagnostic tests,...